Oscar Bustamante-Quintana
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Harnessing DNA barcoding to enhance and sustain polyclonality in gene-edited hematopoietic stem cells.
Journal: Molecular therapy. Methods & clinical development
Published: April 07, 2025
Specific correction of pyruvate kinase deficiency-causing point mutations by CRISPR/Cas9 and single-stranded oligodeoxynucleotides.
Journal: Frontiers in genome editing
Published: November 21, 2022
Gene Editing for Inherited Red Blood Cell Diseases.
Journal: Frontiers in physiology
Published: January 04, 2022
CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders.
Journal: Cytotherapy
Published: December 15, 2021
Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency.
Journal: Molecular therapy. Methods & clinical development
Published: February 02, 2021
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy.
Journal: Frontiers in cell and developmental biology
Published: January 07, 2021
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment.
Journal: Molecular therapy. Methods & clinical development
Published: October 28, 2020
Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10.
Journal: Stem cell research & therapy
Published: August 25, 2020
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells.
Journal: Nature communications
Published: December 23, 2019
Last Updated: 09/26/2026